JP2002526530A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002526530A5 JP2002526530A5 JP2000574510A JP2000574510A JP2002526530A5 JP 2002526530 A5 JP2002526530 A5 JP 2002526530A5 JP 2000574510 A JP2000574510 A JP 2000574510A JP 2000574510 A JP2000574510 A JP 2000574510A JP 2002526530 A5 JP2002526530 A5 JP 2002526530A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- cycloalkyl
- conh
- alkylene
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 63
- 125000001544 thienyl group Chemical group 0.000 description 14
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 description 10
- 125000004076 pyridyl group Chemical group 0.000 description 10
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 8
- 125000000335 thiazolyl group Chemical group 0.000 description 8
- 125000002541 furyl group Chemical group 0.000 description 7
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 7
- 125000000714 pyrimidinyl group Chemical group 0.000 description 7
- 125000000539 amino acid group Chemical group 0.000 description 6
- 125000003016 chromanyl group Chemical group O1C(CCC2=CC=CC=C12)* 0.000 description 5
- 125000001624 naphthyl group Chemical group 0.000 description 5
- -1 phthalimidoyl Chemical group 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 4
- 125000004650 C1-C8 alkynyl group Chemical group 0.000 description 3
- 125000003275 alpha amino acid group Chemical group 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 125000002971 oxazolyl group Chemical group 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- WCFAPJDPAPDDAQ-UHFFFAOYSA-N 1,2-dihydropyrimidine Chemical compound C1NC=CC=N1 WCFAPJDPAPDDAQ-UHFFFAOYSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19845406A DE19845406C2 (de) | 1998-10-02 | 1998-10-02 | Substituierte 1,3-Diaryl-2-pyridin-2-yl-3-(pyridin-2-ylamino)- propanolderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung |
| DE19845406.6 | 1998-10-02 | ||
| PCT/EP1999/006933 WO2000020393A1 (de) | 1998-10-02 | 1999-09-18 | Substituierte 1,3-diaryl-2-pyridin-2-yl-3-(pyridin-2-ylamino)-propanolderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002526530A JP2002526530A (ja) | 2002-08-20 |
| JP2002526530A5 true JP2002526530A5 (https=) | 2006-09-07 |
| JP4544746B2 JP4544746B2 (ja) | 2010-09-15 |
Family
ID=7883187
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000574510A Expired - Fee Related JP4544746B2 (ja) | 1998-10-02 | 1999-09-18 | 置換された１，３−ジアリール−２−ピリド−２−イル−３−（ピリド−２−イルアミノ）プロパノール誘導体、その製造方法、それを含有する医薬およびその使用 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6596728B1 (https=) |
| EP (1) | EP1117642B1 (https=) |
| JP (1) | JP4544746B2 (https=) |
| KR (1) | KR100609255B1 (https=) |
| CN (1) | CN1173951C (https=) |
| AR (1) | AR021845A1 (https=) |
| AT (1) | ATE267809T1 (https=) |
| AU (1) | AU757689B2 (https=) |
| BR (1) | BR9915027B1 (https=) |
| CA (1) | CA2345985C (https=) |
| CZ (1) | CZ299569B6 (https=) |
| DE (2) | DE19845406C2 (https=) |
| DK (1) | DK1117642T3 (https=) |
| ES (1) | ES2219066T3 (https=) |
| HU (1) | HU226688B1 (https=) |
| ID (1) | ID29249A (https=) |
| PL (1) | PL205034B1 (https=) |
| PT (1) | PT1117642E (https=) |
| RU (1) | RU2224748C2 (https=) |
| TR (1) | TR200100896T2 (https=) |
| WO (1) | WO2000020393A1 (https=) |
| ZA (1) | ZA200102587B (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10064402A1 (de) * | 2000-12-21 | 2002-06-27 | Aventis Pharma Gmbh | Diphenylazetidinonderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung |
| MXPA03005019A (es) | 2000-12-21 | 2003-09-25 | Avantis Pharma Deutschland Gmb | Derivados de difenilazetidinonas, metodo para su produccion farmacos que contienen estos compuestos y su uso. |
| EP1420826A2 (de) * | 2001-08-22 | 2004-05-26 | Aventis Pharma Deutschland GmbH | Kombinationspräparate von arylsubstituierten propanolaminderivaten mit weiteren wirkstoffen und deren verwendung |
| US7161008B2 (en) * | 2002-05-03 | 2007-01-09 | Sanofi - Aventis Deutschland GmbH | Optically active β-aminoketones, optically active 1,3-amino alcohols and processes for preparing them |
| DE10219987A1 (de) * | 2002-05-03 | 2004-04-08 | Aventis Pharma Deutschland Gmbh | Optisch aktive β-Aminoketone, optisch aktive 1,3-Aminoalkohole und Verfahren zu deren Herstellung |
| GB0307918D0 (en) | 2003-04-05 | 2003-05-14 | Astrazeneca Ab | Therapeutic use |
| WO2005039506A2 (en) * | 2003-10-24 | 2005-05-06 | Exelixis, Inc. | P70s6 kinase modulators and method of use |
| ES2552657T3 (es) | 2010-05-26 | 2015-12-01 | Satiogen Pharmaceuticals, Inc. | Inhibidores del reciclado de ácidos biliares y saciógenos para el tratamiento de diabetes, obesidad, y afecciones gastrointestinales inflamatorias |
| US20130108573A1 (en) | 2011-10-28 | 2013-05-02 | Lumena Pharmaceuticals, Inc. | Bile Acid Recycling Inhibitors for Treatment of Hypercholemia and Cholestatic Liver Disease |
| AU2012328526B2 (en) | 2011-10-28 | 2017-05-25 | Shire Human Genetic Therapies, Inc. | Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases |
| AU2014229050A1 (en) | 2013-03-15 | 2015-10-22 | Lumena Pharmaceuticals Llc | Bile acid recycling inhibitors for treatment of Barrett's esophagus and gastroesophageal reflux disease |
| CA2907230A1 (en) | 2013-03-15 | 2014-09-18 | Lumena Pharmaceuticals, Inc. | Bile acid recycling inhibitors for treatment of primary sclerosing cholangitis and inflammatory bowel disease |
| JP6361168B2 (ja) * | 2013-06-17 | 2018-07-25 | Jsr株式会社 | 液晶配向剤、液晶配向膜、液晶表示素子、液晶表示素子の製造方法、重合体及び化合物 |
| EP3923943B1 (en) | 2019-02-12 | 2024-07-31 | Mirum Pharmaceuticals, Inc. | Genotype and dose-dependent response to an asbti in patients with bile salt export pump deficiency |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0000816A1 (en) * | 1977-08-06 | 1979-02-21 | Beecham Group Plc | Substituted amino-pyridine derivatives, processes for their preparation and pharmaceutical compositions containing them |
| SU1194273A3 (ru) * | 1981-02-09 | 1985-11-23 | Пфайзер Инк (Фирма) | Способ получени пирбутерола или его аналогов |
| GB9203347D0 (en) * | 1992-02-17 | 1992-04-01 | Wellcome Found | Hypolipidaemic compounds |
| ATE147384T1 (de) * | 1992-02-22 | 1997-01-15 | Hoechst Ag | 4-amino-2-ureido-pyrimidin-5-carbonsäureamide, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| DE19845402B4 (de) * | 1998-10-02 | 2005-04-07 | Aventis Pharma Deutschland Gmbh | Mit Heterocyclen substituierte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung |
| EP0869121B1 (de) * | 1997-04-04 | 2004-06-09 | Aventis Pharma Deutschland GmbH | Hypolipidämische Propanolaminderivate |
| DE19845405C2 (de) * | 1998-10-02 | 2000-07-13 | Aventis Pharma Gmbh | Arylsubstituierte Propanolaminderivate und deren Verwendung |
-
1998
- 1998-10-02 DE DE19845406A patent/DE19845406C2/de not_active Expired - Fee Related
-
1999
- 1999-09-18 AT AT99948791T patent/ATE267809T1/de active
- 1999-09-18 WO PCT/EP1999/006933 patent/WO2000020393A1/de not_active Ceased
- 1999-09-18 CA CA2345985A patent/CA2345985C/en not_active Expired - Fee Related
- 1999-09-18 KR KR1020017004096A patent/KR100609255B1/ko not_active Expired - Fee Related
- 1999-09-18 DE DE59909606T patent/DE59909606D1/de not_active Expired - Lifetime
- 1999-09-18 BR BRPI9915027-1A patent/BR9915027B1/pt not_active IP Right Cessation
- 1999-09-18 CZ CZ20011152A patent/CZ299569B6/cs not_active IP Right Cessation
- 1999-09-18 CN CNB99811636XA patent/CN1173951C/zh not_active Expired - Fee Related
- 1999-09-18 ES ES99948791T patent/ES2219066T3/es not_active Expired - Lifetime
- 1999-09-18 JP JP2000574510A patent/JP4544746B2/ja not_active Expired - Fee Related
- 1999-09-18 RU RU2001111841/04A patent/RU2224748C2/ru not_active IP Right Cessation
- 1999-09-18 PL PL347096A patent/PL205034B1/pl unknown
- 1999-09-18 DK DK99948791T patent/DK1117642T3/da active
- 1999-09-18 TR TR2001/00896T patent/TR200100896T2/xx unknown
- 1999-09-18 HU HU0103533A patent/HU226688B1/hu not_active IP Right Cessation
- 1999-09-18 ID IDW20010736A patent/ID29249A/id unknown
- 1999-09-18 AU AU61926/99A patent/AU757689B2/en not_active Ceased
- 1999-09-18 EP EP99948791A patent/EP1117642B1/de not_active Expired - Lifetime
- 1999-09-18 PT PT99948791T patent/PT1117642E/pt unknown
- 1999-09-30 AR ARP990104960A patent/AR021845A1/es active IP Right Grant
- 1999-10-01 US US09/410,083 patent/US6596728B1/en not_active Expired - Lifetime
-
2001
- 2001-03-29 ZA ZA200102587A patent/ZA200102587B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002526530A5 (https=) | ||
| JP2002501049A5 (https=) | ||
| JP2004532209A5 (https=) | ||
| CA2044515A1 (en) | Cyclic amide derivatives | |
| JP2004529194A5 (https=) | ||
| NO175939C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktiv N1-(1,2-cis-2-halogencyklopropyl)-substituerte pyridonkarboksylsyrederivater, eller et farmasöytisk akseptabelt salt derav, eventuelt i en stereoisomerisk form | |
| JP2001526218A5 (https=) | ||
| JP2005508905A5 (https=) | ||
| JP2003502367A5 (https=) | ||
| JP2005525398A5 (https=) | ||
| JP2005505583A5 (https=) | ||
| JPH10287651A5 (https=) | ||
| RU2224748C2 (ru) | Производные 1,3-диарил-2-пиридин-2-ил-3-(пиридин-2-иламино)пропанола и фармацевтическая композиция на их основе | |
| RU2002130247A (ru) | Производные оксадиазола, обладающие противоопухолевым действием | |
| RU2004107854A (ru) | Производные 4[пиперидин-4-илиден-(3-карбомоилфенил)метил]бензамида и их применение для лечении боли, спинальных повреждений или желудочно-кишечных расстройств | |
| RU2006130686A (ru) | Новые пиперидины в качестве модуляторов хемокинов (ccr) | |
| JP2002539089A5 (https=) | ||
| RU2001111841A (ru) | Замещенные производные 1,3-диарил-2-пиридин-2-ил-3-(пиридин-2-иламино)пропанола, способ их получения, содержащие эти соединения лекарственные средства и их применение | |
| JP2002526550A5 (https=) | ||
| JP2002538117A5 (https=) | ||
| JP2004538314A5 (https=) | ||
| AU2001230588A1 (en) | Preventive or therapeutic agents for gastric or esophageal regurgitation | |
| JP2002538148A5 (https=) | ||
| BR0009080A (pt) | Método de tratamento da apnéia do sono | |
| JP2007525527A5 (https=) |